Details for New Drug Application (NDA): 207516
✉ Email this page to a colleague
The generic ingredient in RISEDRONATE SODIUM is risedronate sodium. There are nineteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the risedronate sodium profile page.
Summary for 207516
Tradename: | RISEDRONATE SODIUM |
Applicant: | Hangzhou Binjiang |
Ingredient: | risedronate sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 207516
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 207516 | ANDA | Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd | 60723-041 | 60723-041-04 | 1 BLISTER PACK in 1 CARTON (60723-041-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01) |
RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 207516 | ANDA | Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd | 60723-041 | 60723-041-12 | 3 BLISTER PACK in 1 CARTON (60723-041-12) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 35MG | ||||
Approval Date: | Feb 15, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription